Literature DB >> 12069872

Cognitive functioning in chronic fatigue syndrome and the role of depression, anxiety, and fatigue.

Keryn Short1, Marita McCabe, Greg Tooley.   

Abstract

OBJECTIVE: This study was designed to investigate the role of depression, anxiety, and fatigue in Chronic Fatigue Syndrome (CFS) sufferers' objective and subjective cognitive performance.
METHODS: Twenty-three CFS sufferers and 23 healthy control participants were compared on objective and subjective assessments of cognitive performance. Depression, anxiety, and fatigue were also evaluated.
RESULTS: CFS sufferers did not demonstrate any impairment in objective cognitive functioning compared to the control group, and objective performance was not related to their higher levels of depression or their level of fatigue. Depression scores only accounted for a small amount of the variance in CFS sufferers' lower subjective assessment of their cognitive performance compared to control participants. There were no differences between the groups on anxiety scores.
CONCLUSION: The results are discussed in terms of the heterogeneity of the CFS population and the complex interaction of symptomatological factors that characterise CFS.

Entities:  

Mesh:

Year:  2002        PMID: 12069872     DOI: 10.1016/s0022-3999(02)00290-8

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  14 in total

1.  Attention network test: assessment of cognitive function in chronic fatigue syndrome.

Authors:  Fumiharu Togo; Gudrun Lange; Benjamin H Natelson; Karen S Quigley
Journal:  J Neuropsychol       Date:  2013-09-24       Impact factor: 2.864

2.  Neuroprotective mechanism of losartan and its interaction with nimesulide against chronic fatigue stress.

Authors:  Anil Kumar; Barinder Singh; Jitendriya Mishra; Sangeeta Pilkhwal Sah; Raghavender Pottabathini
Journal:  Inflammopharmacology       Date:  2015-06-30       Impact factor: 4.473

3.  Subjective quality of life in patients with chronic fatigue syndrome.

Authors:  A Rakib; P D White; A J Pinching; B Hedge; N Newbery; W K Fakhoury; S Priebe
Journal:  Qual Life Res       Date:  2005-02       Impact factor: 4.147

4.  Potential role of pioglitazone, caffeic acid and their combination against fatigue syndrome-induced behavioural, biochemical and mitochondrial alterations in mice.

Authors:  Anil Kumar; Aditi Vashist; Puneet Kumar
Journal:  Inflammopharmacology       Date:  2010-07-03       Impact factor: 4.473

Review 5.  Quality and acceptability of patient-reported outcome measures used in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): a systematic review.

Authors:  Kirstie L Haywood; Sophie Staniszewska; Sarah Chapman
Journal:  Qual Life Res       Date:  2011-05-18       Impact factor: 4.147

Review 6.  Cognitive dysfunction in fibromyalgia and chronic fatigue syndrome: new trends and future directions.

Authors:  Jennifer M Glass
Journal:  Curr Rheumatol Rep       Date:  2006-12       Impact factor: 4.592

7.  Chronic fatigue and indicators of long-term employment disability in psychosomatic inpatients.

Authors:  Karin Tritt; Marius Nickel; Ferdinand Mitterlehner; Cerstin Nickel; Petra Forthuber; Peter Leiberich; Wolfhardt Rother; Thomas Loew
Journal:  Wien Klin Wochenschr       Date:  2004-03-31       Impact factor: 1.704

8.  Cognitive performance is of clinical importance, but is unrelated to pain severity in women with chronic fatigue syndrome.

Authors:  Kelly Ickmans; Mira Meeus; Daphne Kos; Peter Clarys; Geert Meersdom; Luc Lambrecht; Nathalie Pattyn; Jo Nijs
Journal:  Clin Rheumatol       Date:  2013-06-05       Impact factor: 2.980

9.  Reduced cardiac vagal modulation impacts on cognitive performance in chronic fatigue syndrome.

Authors:  Alison Beaumont; Alexander R Burton; Jim Lemon; Barbara K Bennett; Andrew Lloyd; Uté Vollmer-Conna
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

10.  An investigation into the cognitive deficits associated with chronic fatigue syndrome.

Authors:  Marie Thomas; Andrew Smith
Journal:  Open Neurol J       Date:  2009-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.